These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6858121)

  • 1. Role of Clostridium difficile and Campylobacter jejuni in relapses of inflammatory bowel disease.
    Gurian L; Klein K; Ward TT
    West J Med; 1983 Mar; 138(3):359-60. PubMed ID: 6858121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.
    Viscidi R; Willey S; Bartlett JG
    Gastroenterology; 1981 Jul; 81(1):5-9. PubMed ID: 7239125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium difficile in Crohn's disease.
    Wright JM; Adams SP; Gribble MJ; Bowie WR
    Can J Surg; 1984 Sep; 27(5):435-7. PubMed ID: 6478320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of Clostridium difficile from patients with inactive Crohn's disease.
    Dorman SA; Liggoria E; Winn WC; Beeken WL
    Gastroenterology; 1982 Jun; 82(6):1348-51. PubMed ID: 7067956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile associated diarrhoea: a role in inflammatory bowel disease?
    Bolton RP; Sherriff RJ; Read AE
    Lancet; 1980 Feb; 1(8165):383-4. PubMed ID: 6101842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ["Second look" at cytotoxin B of Clostridium difficile in the course of diarrhea associated with antibiotic therapy].
    Sednaoui P; el Mantih B; Cauwell M
    Pathol Biol (Paris); 1999 May; 47(5):415-21. PubMed ID: 10418011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Clostridium difficile infection on pediatric inflammatory bowel disease.
    Pascarella F; Martinelli M; Miele E; Del Pezzo M; Roscetto E; Staiano A
    J Pediatr; 2009 Jun; 154(6):854-8. PubMed ID: 19230908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile and inflammatory bowel disease.
    Bartlett JG
    Gastroenterology; 1981 Apr; 80(4):863-5. PubMed ID: 7202955
    [No Abstract]   [Full Text] [Related]  

  • 9. Campylobacter infection in 682 bulgarian patients with acute enterocolitis, inflammatory bowel disease, and other chronic intestinal diseases.
    Boyanova L; Gergova G; Spassova Z; Koumanova R; Yaneva P; Mitov I; Derejian S; Krastev Z
    Diagn Microbiol Infect Dis; 2004 May; 49(1):71-4. PubMed ID: 15135505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal occurrence of Campylobacter fetus subspecies jejuni and Clostridium difficile in children in Sweden.
    Svedhem A; Kaijser B; MacDowall I
    Eur J Clin Microbiol; 1982 Feb; 1(1):29-32. PubMed ID: 7173168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile infection frequency in patients with nosocomial infections or using antibiotics.
    Gursoy S; Guven K; Arikan T; Yurci A; Torun E; Baskol M; Ozbakir O; Yucesoy M
    Hepatogastroenterology; 2007 Sep; 54(78):1720-4. PubMed ID: 18019703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease.
    Meyer AM; Ramzan NN; Loftus EV; Heigh RI; Leighton JA
    J Clin Gastroenterol; 2004 Oct; 38(9):772-5. PubMed ID: 15365403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of biosite triage Clostridium difficile panel for rapid detection of Clostridium difficile in stool samples.
    Landry ML; Topal J; Ferguson D; Giudetti D; Tang Y
    J Clin Microbiol; 2001 May; 39(5):1855-8. PubMed ID: 11326003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antagonistic activity of Lactobacillus bacteria strains against anaerobic gastrointestinal tract pathogens (Helicobacter pylori, Campylobacter coli, Campylobacter jejuni, Clostridium difficile)].
    Strus M; Pakosz K; Gościniak H; Przondo-Mordarska A; Rozynek E; Pituch H; Meisel-Mikołajczyk F; Heczko PB
    Med Dosw Mikrobiol; 2001; 53(2):133-42. PubMed ID: 11757422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Infectious gastroenteritis in relapses of inflammatory bowel disease. Therapeutic implications].
    Baliellas C; Xiol X; Barenys M; Saavedra J; Casanovas T; Iborra M; Sesé E
    Rev Esp Enferm Dig; 1996 Jun; 88(6):419-22. PubMed ID: 8755323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Clostridium difficile on inflammatory bowel disease.
    Issa M; Vijayapal A; Graham MB; Beaulieu DB; Otterson MF; Lundeen S; Skaros S; Weber LR; Komorowski RA; Knox JF; Emmons J; Bajaj JS; Binion DG
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):345-51. PubMed ID: 17368234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of Clostridium difficile toxin during the course of inflammatory bowel disease.
    Meyers S; Mayer L; Bottone E; Desmond E; Janowitz HD
    Gastroenterology; 1981 Apr; 80(4):697-70. PubMed ID: 7202942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence and origin of Clostridium difficile in neonatology].
    Manso E; Strusi P; Stacchiotti MA; Vincenzi R; Tiriduzzi M; Del Prete U
    Boll Ist Sieroter Milan; 1986; 65(2):118-24. PubMed ID: 3741636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clostridium difficile toxin A and other enteropathogens in stool specimens of children hospitalized due to acute diarrhoea].
    Rozkiewicz D; Zaremba ML; Fiedoruk K; Daniluk T; Sciepuk M; Kurzatkowska B; Sulik A; Ołdak E
    Przegl Epidemiol; 2005; 59(3):711-21. PubMed ID: 16433313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic implications of Clostridium difficile toxin during relapse of chronic inflammatory bowel disease.
    LaMont JT; Trnka YM
    Lancet; 1980 Feb; 1(8165):381-3. PubMed ID: 6101841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.